Caraway raised a $16.75 million Series A to expand access to medication abortion and broaden its focus from women to all members of Gen Z, CEO Lori Evans Bernstein tells Axios exclusively.
Why it matters: The raise comes as young people embrace gender diversity while facing reduced access to reproductive support — and reflects continued VC appetite for reproductive health, even as some of the sector's earliest startups flounder.
